MCK
Price
$786.00
Change
+$10.56 (+1.36%)
Updated
Oct 17 closing price
Capitalization
97.77B
18 days until earnings call
SNYR
Price
$2.69
Change
+$0.32 (+13.50%)
Updated
Oct 17 closing price
Capitalization
30.11M
Interact to see
Advertisement

MCK vs SNYR

Header iconMCK vs SNYR Comparison
Open Charts MCK vs SNYRBanner chart's image
McKesson
Price$786.00
Change+$10.56 (+1.36%)
Volume$621.06K
Capitalization97.77B
Synergy CHC
Price$2.69
Change+$0.32 (+13.50%)
Volume$178.67K
Capitalization30.11M
MCK vs SNYR Comparison Chart in %
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCK vs. SNYR commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCK is a Hold and SNYR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (MCK: $786.00 vs. SNYR: $2.69)
Brand notoriety: MCK: Notable vs. SNYR: Not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MCK: 86% vs. SNYR: 141%
Market capitalization -- MCK: $97.77B vs. SNYR: $30.11M
MCK [@Medical Distributors] is valued at $97.77B. SNYR’s [@Medical Distributors] market capitalization is $30.11M. The market cap for tickers in the [@Medical Distributors] industry ranges from $97.77B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCK’s FA Score shows that 4 FA rating(s) are green whileSNYR’s FA Score has 0 green FA rating(s).

  • MCK’s FA Score: 4 green, 1 red.
  • SNYR’s FA Score: 0 green, 5 red.
According to our system of comparison, MCK is a better buy in the long-term than SNYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCK’s TA Score shows that 6 TA indicator(s) are bullish while SNYR’s TA Score has 7 bullish TA indicator(s).

  • MCK’s TA Score: 6 bullish, 4 bearish.
  • SNYR’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, SNYR is a better buy in the short-term than MCK.

Price Growth

MCK (@Medical Distributors) experienced а +2.94% price change this week, while SNYR (@Medical Distributors) price change was +20.63% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.24%. For the same industry, the average monthly price growth was +3.69%, and the average quarterly price growth was +11.79%.

Reported Earning Dates

MCK is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical Distributors (+1.24% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCK($97.8B) has a higher market cap than SNYR($30.1M). MCK has higher P/E ratio than SNYR: MCK (31.48) vs SNYR (7.08). MCK YTD gains are higher at: 38.371 vs. SNYR (-38.864). MCK has higher annual earnings (EBITDA): 5.19B vs. SNYR (8.8M). MCK has more cash in the bank: 2.42B vs. SNYR (1.46M). SNYR has less debt than MCK: SNYR (26.9M) vs MCK (9.93B). MCK has higher revenues than SNYR: MCK (378B) vs SNYR (33.7M).
MCKSNYRMCK / SNYR
Capitalization97.8B30.1M324,917%
EBITDA5.19B8.8M58,973%
Gain YTD38.371-38.864-99%
P/E Ratio31.487.08445%
Revenue378B33.7M1,121,662%
Total Cash2.42B1.46M165,730%
Total Debt9.93B26.9M36,926%
FUNDAMENTALS RATINGS
MCK vs SNYR: Fundamental Ratings
MCK
SNYR
OUTLOOK RATING
1..100
219
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
62
Fair valued
PROFIT vs RISK RATING
1..100
477
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
1765
P/E GROWTH RATING
1..100
1961
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCK's Valuation (23) in the Medical Distributors industry is somewhat better than the same rating for SNYR (62) in the null industry. This means that MCK’s stock grew somewhat faster than SNYR’s over the last 12 months.

MCK's Profit vs Risk Rating (4) in the Medical Distributors industry is significantly better than the same rating for SNYR (77) in the null industry. This means that MCK’s stock grew significantly faster than SNYR’s over the last 12 months.

MCK's SMR Rating (100) in the Medical Distributors industry is in the same range as SNYR (100) in the null industry. This means that MCK’s stock grew similarly to SNYR’s over the last 12 months.

MCK's Price Growth Rating (17) in the Medical Distributors industry is somewhat better than the same rating for SNYR (65) in the null industry. This means that MCK’s stock grew somewhat faster than SNYR’s over the last 12 months.

MCK's P/E Growth Rating (19) in the Medical Distributors industry is somewhat better than the same rating for SNYR (61) in the null industry. This means that MCK’s stock grew somewhat faster than SNYR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCKSNYR
RSI
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 4 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
37%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
35%
Advances
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 16 days ago
39%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
40%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MFIC11.680.15
+1.30%
MidCap Financial Investment Corp
CDXS2.650.01
+0.38%
Codexis
AJG280.470.30
+0.11%
Arthur J Gallagher & Co
FOUR73.88-0.20
-0.27%
Shift4 Payments
MSW2.28-0.05
-2.15%
Ming Shing Group Holdings Ltd

MCK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCK has been closely correlated with COR. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MCK jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCK
1D Price
Change %
MCK100%
+1.36%
COR - MCK
72%
Closely correlated
+1.66%
CAH - MCK
63%
Loosely correlated
+2.05%
HSIC - MCK
13%
Poorly correlated
+1.53%
SHTDF - MCK
9%
Poorly correlated
-4.27%
OMI - MCK
3%
Poorly correlated
+4.58%
More

SNYR and

Correlation & Price change

A.I.dvisor tells us that SNYR and ZYXI have been poorly correlated (+-1% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYR and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYR
1D Price
Change %
SNYR100%
+13.50%
ZYXI - SNYR
-1%
Poorly correlated
-0.75%
CAH - SNYR
-3%
Poorly correlated
+2.05%
COSM - SNYR
-4%
Poorly correlated
-5.05%
HSIC - SNYR
-7%
Poorly correlated
+1.53%
MCK - SNYR
-7%
Poorly correlated
+1.36%
More